Johannes W Jansen

Title: Innovations of Johannes W Jansen

Introduction

Johannes W Jansen is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with fibrinolytic properties. With a total of 4 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Jansen's latest patents include innovative compounds such as 8,9-annelated-β-carbolines and 8,9-annelated-3,4-dihydro-β-carbolines. These compounds exhibit interesting fibrinolytic properties and can be used as orally active fibrinolytics. The general formulae of these compounds involve a heterocyclic group consisting of 5-10 ring atoms. Additionally, he has developed new 8,9-annelated-1,2,3,4-tetrahydro-β-carboline derivatives, which also have pharmaceutical applications. A method for dissolving blood clots using these compounds is part of his recent inventions.

Career Highlights

Johannes W Jansen is associated with Duphar International Research Bv, where he has been instrumental in advancing research in his field. His work has led to the development of compounds that could revolutionize the treatment of conditions related to blood clotting.

Collaborations

Some of his notable coworkers include Derk Hamminga and Ineke Van Wijngaarden, who have collaborated with him on various projects.

Conclusion

Johannes W Jansen's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.